<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Medicine (Baltimore)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Medicine (Baltimore)</journal-id>
      <journal-id journal-id-type="publisher-id">MEDI</journal-id>
      <journal-title-group>
        <journal-title>Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0025-7974</issn>
      <issn pub-type="epub">1536-5964</issn>
      <publisher>
        <publisher-name>Wolters Kluwer Health</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27603334</article-id>
      <article-id pub-id-type="pmc">5023856</article-id>
      <article-id pub-id-type="doi">10.1097/MD.0000000000004345</article-id>
      <article-id pub-id-type="art-access-id">04345</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>6900</subject>
        </subj-group>
        <subj-group>
          <subject>Research Article</subject>
          <subject>Clinical Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Bilateral sudden sensorineural hearing loss as a presenting feature of systemic lupus erythematosus</article-title>
        <subtitle>Case report and brief review of other published cases</subtitle>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Chawki</surname>
            <given-names>Sylvain</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>a</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>b</sup>
          </xref>
          <xref>
            <sup>&#x2217;</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Aouizerate</surname>
            <given-names>Jessie</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="aff3">
            <sup>c</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Trad</surname>
            <given-names>Selim</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="aff1">
            <sup>a</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>b</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Prinseau</surname>
            <given-names>Jacques</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="aff1">
            <sup>a</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>b</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hanslik</surname>
            <given-names>Thomas</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="aff1">
            <sup>a</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>b</sup>
          </xref>
          <xref ref-type="aff" rid="aff4">
            <sup>d</sup>
          </xref>
          <xref ref-type="aff" rid="aff5">
            <sup>e</sup>
          </xref>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Astete.</surname>
            <given-names>Carlos Guillen</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>a</label>Service de M&#xE9;decine Interne, H&#xF4;pital Ambroise Par&#xE9;, Assistance Publique H&#xF4;pitaux de Paris, APHP, Boulogne Billancourt</aff>
      <aff id="aff2"><label>b</label>Universit&#xE9; de Versailles Saint Quentin en Yvelines, UVSQ, Versailles</aff>
      <aff id="aff3"><label>c</label>Service de N&#xE9;phrologie, H&#xF4;pital Henri Mondor, Assistance Publique H&#xF4;pitaux de Paris, APHP, Cr&#xE9;teil</aff>
      <aff id="aff4"><label>d</label>Institut Pierre Louis d&#x2019;Epid&#xE9;miologie et de Sant&#xE9; Publique, Sorbonne Universit&#xE9;s, UPMC Univ Paris 06, UMR_S 1136</aff>
      <aff id="aff5"><label>e</label>INSERM, UMR_S 1136, Institut Pierre Louis d&#x2019;Epid&#xE9;miologie et de Sant&#xE9; Publique, Paris, France.</aff>
      <author-notes id="cor1">
        <corresp><label>&#x2217;</label>Correspondence: Sylvain Chawki, 20 avenue Corot, Le Vesinet 78110, France (e-mail: <email>sylvain.chawki@gmail.com</email>).</corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <month>9</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>09</day>
        <month>9</month>
        <year>2016</year>
      </pub-date>
      <volume>95</volume>
      <issue>36</issue>
      <elocation-id>e4345</elocation-id>
      <history>
        <date date-type="received">
          <day>4</day>
          <month>4</month>
          <year>2016</year>
        </date>
        <date date-type="rev-recd">
          <day>23</day>
          <month>6</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>25</day>
          <month>6</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2016 the Author(s). Published by Wolters Kluwer Health, Inc. All rights reserved.</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0">
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially. <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0">http://creativecommons.org/licenses/by-nc-nd/4.0</ext-link></license-p>
        </license>
      </permissions>
      <self-uri xlink:type="simple" xlink:href="medi-95-e4345.pdf"/>
      <abstract>
        <title>Abstract</title>
        <sec sec-type="intro">
          <title>Introduction:</title>
          <p>Sudden sensorineural hearing loss is an unusual presenting clinical feature of systemic lupus erythematosus.</p>
        </sec>
        <sec>
          <title>Case report:</title>
          <p>We report the case of a young woman who was admitted to hospital for sudden sensorineural hearing loss and hemophagocytic syndrome which was attributed to systemic lupus erythematosus on the basis of specific renal involvement, thrombocytopenia, and consistent autoantibodies. Favorable outcome was obtained on high-dose corticosteroids, and the hearing fully recovered.</p>
        </sec>
        <sec sec-type="discussion">
          <title>Discussion:</title>
          <p>Sudden sensorineural hearing loss in systemic lupus erythematosus is seemingly more frequently associated with severe systemic involvement and antiphospholipid antibodies may be present. Although management remains empirical, the high risk of permanent hearing impairment seems to justify emergency treatment with high-dose corticosteroids. When the clinical and laboratory criteria of antiphospholipid syndrome are met, antiplatelets agents or anticoagulation therapy shall be considered.</p>
        </sec>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>autoimmunity</kwd>
        <kwd>corticosteroids</kwd>
        <kwd>sensorineural hearing loss</kwd>
        <kwd>systemic lupus erythematosus</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>OPEN-ACCESS</meta-name>
          <meta-value>TRUE</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <label>1</label>
      <title>Introduction</title>
      <p>Sudden sensorineural hearing loss is defined as an acquired hearing deficit of up to 30&#x200A;dB loss in 3 different frequencies on an audiogram, building up over a few hours to up to 3 days. Five to 20 per 100,000 population are affected, both male and female, typically between 30 and 60 years of age.<sup>[<xref rid="R1" ref-type="bibr">1</xref>]</sup> In the majority of cases, hearing loss is unilateral and associated with vestibular symptoms. The pathophysiology is unclear. Viral, genetic, traumatic, or toxic causes have been discussed. Autoimmune or vascular etiology has been put forward in 10% of cases.<sup>[<xref rid="R2" ref-type="bibr">2</xref>]</sup></p>
      <p>Sudden sensorineural hearing loss is an unusual presenting clinical feature of systemic lupus erythematosus. We report the case of a young woman who presented to our hospital for sudden sensorineural hearing loss that was ultimately attributed to systemic lupus erythematosus. We reviewed the medical literature indexed in the Medline database (accessed on December 28, 2015). Our search key words were: &#x201C;hearing OR sensorineural OR deafness AND lupus,&#x201D; in all fields, only English and French language articles.</p>
    </sec>
    <sec>
      <label>2</label>
      <title>Case report</title>
      <p>A 19-year-old woman was referred to our hospital in December 2006 for a fever, a sudden profound bilateral hearing loss and a malar rash that had appeared 10 days before hospitalization. She had no significant past medical history. Besides hearing loss, physical examination revealed a malar rash, ulcerated stomatitis, enlarged cervical lymph nodes, and subungual hemorrhage. The remainder of the physical examination was normal.</p>
      <p>An audiogram showed a hearing threshold of 40&#x200A;dB in the right ear and 60&#x200A;dB in the left ear, both in air and bone conduction. Laboratory tests revealed neutropenia (540&#x200A;neutrophils/&#x3BC;L), thrombocytopenia (125,000/&#x3BC;L), elevated liver enzymes (aspartate aminotransferase 247&#x200A;IU/L, 8-fold the upper limit of normal range; alanine transaminase 116&#x200A;IU/L, 3-fold the upper limit of normal range; gamma-glutamyl transferase 166&#x200A;IU/L, 3-fold the upper limit of normal range and alkaline phosphatase 40&#x200A;IU/L, normal), hyperferritinemia (10,965&#x200A;&#x3BC;g/L) and an elevated titer of lactate dehydrogenase (989&#x200A;IU/L, 3-fold the upper limit of normal range), and triglycerides (4.96&#x200A;g/L, normal range: 0.6&#x2013;1.9&#x200A;g/L). Hematuria and leucocyturia were initially detected, with an associated proteinuria (3.13&#x200A;g/L).</p>
      <p>Antinuclear antibodies were positive (titer 1/2560), with antidouble stranded DNA (31&#x200A;IU) and anti-Sm antibodies. Antinucleosome and anti-SSA antibodies were present as well. Coagulation tests disclosed a lupus anticoagulant. Low levels of anticardiolipin antibodies were detected (IgG: 27&#x200A;&#x3BC;g/L).</p>
      <p>Complement was abnormally low with 0.3&#x200A;g/L C3 (lower limit 0.7&#x200A;g/L); 0.1&#x200A;g/L C4 (lower limit 0.1&#x200A;g/L) and 50% CH50%. Bone marrow aspiration revealed mild hemophagocytosis.</p>
      <p>Renal biopsy revealed World Health Organisation class II lupus nephritis with pure mesangial involvement, with IgG, C3, C1q, and IgM deposits on immunofluorescence. There was no alteration of blood vessels (absence of infiltration, necrosis of the vascular wall, or microscopic thromboangiitis), nor proliferation on light microscopy.</p>
      <p>Echocardiographic examination was normal, without any valvular abnormality. Cerebral magnetic resonance imaging was normal and displayed no evidence of ischemia.</p>
      <p>The patient met the American College of Rheumatology classification criteria for systemic lupus erythematosus. She was treated with high-dose (500&#x200A;mg) intravenous methylprednisolone for 3 days, and clinically improved within a few days. The hearing completely recovered, as assessed by repeated audiograms. The hemophagocytic syndrome, proteinuria, and hematuria also improved following corticosteroid therapy.</p>
      <p>Long-term treatment with prednisone (1&#x200A;mg/kg/day with gradual decrease), hydroxychloroquine and aspirin was introduced. Six months later, proteinuria and hematuria rebounded and mycophenolate mofetil treatment was introduced. Overall treatment was well tolerated. One year later, clinical examination was normal with a complete remission of systemic lupus erythematosus; mycophenolate mofetil was stopped.</p>
      <p>Secondary antiphospholipid syndrome (antiphospholipid syndrome) was excluded on the basis of an uneventful follow-up and the quick fading of anticardiolipin antibodies and lupus anticoagulant that were never detected again over 9 years of follow-up.</p>
      <p>A second flare occurred in 2011, with myalgia, arthralgia, fatigue, and hemophagocytic syndrome. This flare was treated by a temporary increase of prednisone dose; no immunosuppressive therapy was necessary. Evolution was unremarkable ever since. When last seen in February 2016, the patient was doing well on 5&#x200A;mg prednisone and 400&#x200A;mg hydroxychloroquine daily.</p>
    </sec>
    <sec>
      <label>3</label>
      <title>Discussion</title>
      <p>This patient presented with bilateral sudden sensorineural hearing loss in the context of a hemophagocytic syndrome, revealing systemic lupus erythematosus, and raising questions about pathophysiology and treatment. Sudden sensorineural hearing loss should be clearly distinguished from other sensorineural hearing loss in patients with systemic lupus erythematosus. Indeed, systematic audiometric tests have shown that 20% to 55% of systemic lupus erythematosus patients have chronic sensorineural hearing impairment, often asymptomatic.<sup>[<xref rid="R3" ref-type="bibr">3</xref>&#x2013;<xref rid="R8" ref-type="bibr">8</xref>]</sup> Thus, the risk of sensorineural hearing loss seems to be much higher in systemic lupus erythematosus patients compared to healthy age-matched controls, with an odds ratio of 20 (95% CI: 2.93&#x2013;139.6).<sup>[<xref rid="R7" ref-type="bibr">7</xref>]</sup> In contrast, sudden sensorineural hearing loss, which is usually a dramatic condition, has been seldom reported in systemic lupus erythematosus patients (Table <xref ref-type="table" rid="T1">1</xref>).</p>
      <table-wrap id="T1" position="float">
        <label>Table 1</label>
        <caption>
          <p>Published case reports of sudden sensorineural hearing loss in patients with systemic lupus erythematosus.</p>
        </caption>
        <graphic xlink:href="medi-95-e4345-g001"/>
      </table-wrap>
      <p>Three pathophysiological hypotheses are proposed for sudden sensorineural hearing loss at the beginning of systemic lupus erythematosus manifestations<sup>[<xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R10" ref-type="bibr">10</xref>]</sup>:.<list list-type="bullet"><list-item><p>T-cell autoimmunity: As shown patients with sudden sensorineural hearing loss presented significant proliferation of T lymphocytes specifically responsive to human inner ear antigens, as well as increased interferon-gamma and other inflammatory intracellular cytokines levels in peripheral blood.<sup>[<xref rid="R11" ref-type="bibr">11</xref>&#x2013;<xref rid="R16" ref-type="bibr">16</xref>]</sup></p></list-item><list-item><p>Humoral autoimmunity: specific autoantibodies directed against inner-ear antigens have been detected in this context and may be involved in sudden hearing loss.<sup>[<xref rid="R17" ref-type="bibr">17</xref>&#x2013;<xref rid="R19" ref-type="bibr">19</xref>]</sup></p></list-item><list-item><p>Antiphospholipid syndrome: case reports have highlighted the possible association of anticardiolipin antibodies with sudden sensorineural hearing loss in systemic lupus erythematosus. Antiphospholipid antibodies (i.e., anticardiolipin antibody, lupus anticoagulant, and anti-&#x3B2;2 GP1) are known to be associated with microcirculation thrombosis and histological proof of microinfarctions has been reported in systemic lupus erythematosus patients with sudden sensorineural hearing loss.<sup>[<xref rid="R20" ref-type="bibr">20</xref>&#x2013;<xref rid="R22" ref-type="bibr">22</xref>]</sup> High concentrations of antiphospholipid antibodies have been reported in case reports of lupus-associated sudden sensorineural hearing loss, with satisfying clinical response to anticoagulant therapy.<sup>[<xref rid="R20" ref-type="bibr">20</xref>,<xref rid="R22" ref-type="bibr">22</xref>&#x2013;<xref rid="R26" ref-type="bibr">26</xref>]</sup> Whether the presence of antiphospholipid antibodies in patients presenting sudden sensorineural hearing loss is sufficient to establish a diagnosis of secondary antiphospholipid syndrome in the absence of other symptoms (i.e., thromboembolic or obstetrical complications) remains to be determined.<sup>[<xref rid="R20" ref-type="bibr">20</xref>,<xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R24" ref-type="bibr">24</xref>,<xref rid="R25" ref-type="bibr">25</xref>]</sup></p></list-item></list></p>
      <p>When reviewing the English and French literature in the Medline database, we found 22 documented cases of sudden sensorineural hearing loss in association with systemic lupus erythematosus (Table <xref ref-type="table" rid="T1">1</xref>). Patients were between 20 and 50 years old, mostly women (16/22). Hearing loss was unilateral in 14 out of 22 cases. Hearing loss was the first manifestation of systemic lupus erythematosus in four cases. In 11 cases major systemic involvement of systemic lupus erythematosus such as renal, cardiac, or neurological involvement was also reported.</p>
      <p>Besides hearing loss, other reported aural symptoms included: middle ear involvement, otitis, and in 9 cases, vestibular symptoms.</p>
      <p>When tested, anticardiolipin antibodies, and/or lupus anticoagulant and/or isolated syphilis reaginic antibody proved positive in 11 out of 15 cases. Half of these patients had a past or present medical history of thrombosis. Ten patients had had a brain CT-scan or MRI: among them, 3 had signs of central nervous system ischemia. However, secondary antiphospholipid syndrome was not explicitly considered in several of those cases. Pathological data were available in three cases, showing middle ear lesions such as vasculitis and nonspecific inflammation.</p>
      <p>Twelve patients were treated with steroids (0.5&#x2013;1&#x200A;mg/kg equivalent prednisone, 1 was treated with 500&#x200A;mg methylprednisonolone on 3 consecutive days), 4 patients were prescribed immunosuppressive therapy with azathioprine or cyclophosphamide, 3 were treated with plasmapheresis and 2 with hydroxychloroquine. Anticoagulation or antiplatelet therapy was prescribed to 4 patients. Clinical outcome was reported for 13 patients: recovery from hearing loss was complete in only 4 patients and partial in 2 other cases. None of the patients treated with anticoagulation or antiplatelet therapy recovered.</p>
      <p>A recent publication of a retrospective cohort study from the Taiwan National Health Insurance Research Database reported 27 cases of sudden sensorineural hearing loss associated with systemic lupus erythematosus, but no detail on clinical and biological data was available.<sup>[<xref rid="R27" ref-type="bibr">27</xref>]</sup></p>
      <p>We conclude that sudden sensorineural hearing loss can be the presenting clinical feature of systemic lupus erythematosus and may be associated with antiphospholipid antibodies. Although management of such cases remains empirical, the high risk of permanent hearing loss seems to justify emergency treatment with high dose corticosteroids. If the laboratory criteria of antiphospholipid syndrome are present, antiplatelets agents or anticoagulation therapy shall be considered.</p>
      <p>Informed oral consent was obtained from the patient.</p>
      <p>All data were strictly obtained from the patient's medical file.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="COI-statement">
        <p>The authors have no conflicts of interest to disclose.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stachler</surname><given-names>RJ</given-names></name><name><surname>Chandrasekhar</surname><given-names>SS</given-names></name><name><surname>Archer</surname><given-names>SM</given-names></name><etal/></person-group>
<article-title>Clinical practice guideline: sudden hearing loss</article-title>. <source><italic>Otolaryngol Head Neck Surg</italic></source>
<year>2012</year>; <volume>146</volume>:<fpage>S1</fpage>&#x2013;<lpage>S35</lpage>.<pub-id pub-id-type="pmid">22383545</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vinceneux</surname><given-names>P</given-names></name><name><surname>Couloigner</surname><given-names>V</given-names></name><name><surname>Pouchot</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Autoimmune deafness</article-title>. <source><italic>Presse Med</italic></source>
<year>1999</year>; <volume>28</volume>:<fpage>1904</fpage>&#x2013;<lpage>1910</lpage>.<pub-id pub-id-type="pmid">10587729</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbasi</surname><given-names>M</given-names></name><name><surname>Yazdi</surname><given-names>Z</given-names></name><name><surname>Kazemifar</surname><given-names>AM</given-names></name><etal/></person-group>
<article-title>Hearing loss in patients with systemic lupus erythematosus</article-title>. <source><italic>Glob J Health Sci</italic></source>
<year>2013</year>; <volume>5</volume>:<fpage>102</fpage>&#x2013;<lpage>106</lpage>.<pub-id pub-id-type="pmid">23985111</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andonopoulos</surname><given-names>AP</given-names></name><name><surname>Naxakis</surname><given-names>S</given-names></name><name><surname>Goumas</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Sensorineural hearing disorders in systemic lupus erythematosus. A controlled study</article-title>. <source><italic>Clin Exp Rheumatol</italic></source>
<year>1995</year>; <volume>13</volume>:<fpage>137</fpage>&#x2013;<lpage>141</lpage>.<pub-id pub-id-type="pmid">7656458</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowman</surname><given-names>CA</given-names></name><name><surname>Linthicum</surname><given-names>FH</given-names><suffix>Jr</suffix></name><name><surname>Nelson</surname><given-names>RA</given-names></name><etal/></person-group>
<article-title>Sensorineural hearing loss associated with systemic lupus erythematosus</article-title>. <source><italic>Otolaryngol Head Neck Surg</italic></source>
<year>1986</year>; <volume>94</volume>:<fpage>197</fpage>&#x2013;<lpage>204</lpage>.<pub-id pub-id-type="pmid">3083335</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kastanioudakis</surname><given-names>I</given-names></name><name><surname>Ziavra</surname><given-names>N</given-names></name><name><surname>Voulgari</surname><given-names>PV</given-names></name><etal/></person-group>
<article-title>Ear involvement in systemic lupus erythematosus patients: a comparative study</article-title>. <source><italic>J Laryngol Otol</italic></source>
<year>2002</year>; <volume>116</volume>:<fpage>103</fpage>&#x2013;<lpage>107</lpage>.<pub-id pub-id-type="pmid">11827581</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roverano</surname><given-names>S</given-names></name><name><surname>Cassano</surname><given-names>G</given-names></name><name><surname>Paira</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Asymptomatic sensorineural hearing loss in patients with systemic lupus erythematosus</article-title>. <source><italic>J Clin Rheumatol</italic></source>
<year>2006</year>; <volume>12</volume>:<fpage>217</fpage>&#x2013;<lpage>220</lpage>.<pub-id pub-id-type="pmid">17023806</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sperling</surname><given-names>NM</given-names></name><name><surname>Tehrani</surname><given-names>K</given-names></name><name><surname>Liebling</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Aural symptoms and hearing loss in patients with lupus</article-title>. <source><italic>Otolaryngol Head Neck Surg</italic></source>
<year>1998</year>; <volume>118</volume>:<fpage>762</fpage>&#x2013;<lpage>765</lpage>.<pub-id pub-id-type="pmid">9627233</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcucchi</surname><given-names>R</given-names></name><name><surname>Alessandrello Liotta</surname><given-names>A</given-names></name><name><surname>Cellai</surname><given-names>AP</given-names></name><etal/></person-group>
<article-title>Cardiovascular and thrombophilic risk factors for idiopathic sudden sensorineural hearing loss</article-title>. <source><italic>J Thromb Haemost</italic></source>
<year>2005</year>; <volume>3</volume>:<fpage>929</fpage>&#x2013;<lpage>934</lpage>.<pub-id pub-id-type="pmid">15869586</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yehudai</surname><given-names>D</given-names></name><name><surname>Shoenfeld</surname><given-names>Y</given-names></name><name><surname>Toubi</surname><given-names>E</given-names></name></person-group>
<article-title>The autoimmune characteristics of progressive or sudden sensorineural hearing loss</article-title>. <source><italic>Autoimmunity</italic></source>
<year>2006</year>; <volume>39</volume>:<fpage>153</fpage>&#x2013;<lpage>158</lpage>.<pub-id pub-id-type="pmid">16698672</pub-id></mixed-citation>
      </ref>
      <ref id="R11">
        <label>11</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>JP</given-names></name><name><surname>Woolf</surname><given-names>NK</given-names></name><name><surname>Ryan</surname><given-names>AF</given-names></name></person-group>
<article-title>A re-examination of experimental type II collagen autoimmunity: middle and inner ear morphology and function</article-title>. <source><italic>Ann Otol Rhinol Laryngol</italic></source>
<year>1986</year>; <volume>95</volume>:<fpage>176</fpage>&#x2013;<lpage>180</lpage>.<pub-id pub-id-type="pmid">3963690</pub-id></mixed-citation>
      </ref>
      <ref id="R12">
        <label>12</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>GB</given-names></name><name><surname>Barna</surname><given-names>BP</given-names></name><name><surname>Kinney</surname><given-names>SE</given-names></name><etal/></person-group>
<article-title>Predictive value of laboratory tests in &#x201C;autoimmune&#x201D; inner ear disease: preliminary report</article-title>. <source><italic>Laryngoscope</italic></source>
<year>1986</year>; <volume>96</volume>:<fpage>502</fpage>&#x2013;<lpage>505</lpage>.<pub-id pub-id-type="pmid">3702564</pub-id></mixed-citation>
      </ref>
      <ref id="R13">
        <label>13</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwai</surname><given-names>H</given-names></name><name><surname>Tomoda</surname><given-names>K</given-names></name><name><surname>Sugiura</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>T cells infiltrating from the systemic circulation proliferate in the endolymphatic sac</article-title>. <source><italic>Ann Otol Rhinol Laryngol</italic></source>
<year>1999</year>; <volume>108</volume>:<fpage>1146</fpage>&#x2013;<lpage>1150</lpage>.<pub-id pub-id-type="pmid">10605919</pub-id></mixed-citation>
      </ref>
      <ref id="R14">
        <label>14</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenz</surname><given-names>RR</given-names></name><name><surname>Solares</surname><given-names>CA</given-names></name><name><surname>Williams</surname><given-names>PM</given-names></name><etal/></person-group>
<article-title>Interferongamma production to inner ear antigens by T cells from patients with autoimmune sensorineural hearing loss</article-title>. <source><italic>J Neuroimmunol</italic></source>
<year>2002</year>; <volume>130</volume>:<fpage>173</fpage>&#x2013;<lpage>178</lpage>.<pub-id pub-id-type="pmid">12225899</pub-id></mixed-citation>
      </ref>
      <ref id="R15">
        <label>15</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staecker</surname><given-names>H</given-names></name><name><surname>Lefebvre</surname><given-names>PP</given-names></name></person-group>
<article-title>Autoimmune sensorineural hearing loss improved by tumor necrosis factor-alpha blockade: a case report</article-title>. <source><italic>Acta Otolaryngol</italic></source>
<year>2002</year>; <volume>122</volume>:<fpage>684</fpage>&#x2013;<lpage>687</lpage>.<pub-id pub-id-type="pmid">12403135</pub-id></mixed-citation>
      </ref>
      <ref id="R16">
        <label>16</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoo</surname><given-names>TJ</given-names></name></person-group>
<article-title>Etiopathogenesis of Meniere's disease: a hypothesis</article-title>. <source><italic>Ann Otol Rhinol Laryngol Suppl</italic></source>
<year>1984</year>; <volume>113</volume>:<fpage>6</fpage>&#x2013;<lpage>12</lpage>.<pub-id pub-id-type="pmid">6207756</pub-id></mixed-citation>
      </ref>
      <ref id="R17">
        <label>17</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnold</surname><given-names>W</given-names></name><name><surname>Pfaltz</surname><given-names>CR</given-names></name></person-group>
<article-title>Critical evaluation of the immunofluorescence microscopic test for identification of serum antibodies against human inner ear tissue</article-title>. <source><italic>Acta Otolaryngol</italic></source>
<year>1987</year>; <volume>103</volume>:<fpage>373</fpage>&#x2013;<lpage>378</lpage>.<pub-id pub-id-type="pmid">3303821</pub-id></mixed-citation>
      </ref>
      <ref id="R18">
        <label>18</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gebbers</surname><given-names>JO</given-names></name><name><surname>Altermatt</surname><given-names>HJ</given-names></name><name><surname>Arnold</surname><given-names>W</given-names></name><etal/></person-group>
<article-title>Binding of serum immunoglobulins to human inner ear tissue in inner ear hearing loss</article-title>. <source><italic>HNO</italic></source>
<year>1987</year>; <volume>35</volume>:<fpage>487</fpage>&#x2013;<lpage>491</lpage>.<pub-id pub-id-type="pmid">3323147</pub-id></mixed-citation>
      </ref>
      <ref id="R19">
        <label>19</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>JP</given-names></name></person-group>
<article-title>Immunology of the inner ear: immunology of the inner ear: evidence of local antibody production</article-title>. <source><italic>Ann Otol Rhinol Laryngol</italic></source>
<year>1984</year>; <volume>93</volume>:<fpage>157</fpage>&#x2013;<lpage>162</lpage>.<pub-id pub-id-type="pmid">6712089</pub-id></mixed-citation>
      </ref>
      <ref id="R20">
        <label>20</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Compadretti</surname><given-names>GC</given-names></name><name><surname>Brandolini</surname><given-names>C</given-names></name><name><surname>Tasca</surname><given-names>I</given-names></name></person-group>
<article-title>Sudden SNHL in lupus erythematosus associated with antiphospholipid syndrome</article-title>. <source><italic>Ann Otol Rhinol Laryngol</italic></source>
<year>2005</year>; <volume>114</volume>:<fpage>214</fpage>&#x2013;<lpage>218</lpage>.<pub-id pub-id-type="pmid">15825571</pub-id></mixed-citation>
      </ref>
      <ref id="R21">
        <label>21</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>L</given-names></name><name><surname>Miller</surname><given-names>EB</given-names></name></person-group>
<article-title>Sudden sensorineural hearing loss as a first manifestation of systemic lupus erythematosus: association with anticardiolipin antibodies</article-title>. <source><italic>Clin Rheumatol</italic></source>
<year>2001</year>; <volume>20</volume>:<fpage>220</fpage>&#x2013;<lpage>222</lpage>.<pub-id pub-id-type="pmid">11434477</pub-id></mixed-citation>
      </ref>
      <ref id="R22">
        <label>22</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naarendrop</surname><given-names>M</given-names></name><name><surname>Spiera</surname><given-names>H</given-names></name></person-group>
<article-title>Sudden SNHL in patients with SLE and antiphospholipid antibodies</article-title>. <source><italic>J Rheumatol</italic></source>
<year>1998</year>; <volume>25</volume>:<fpage>589</fpage>&#x2013;<lpage>592</lpage>.<pub-id pub-id-type="pmid">9517786</pub-id></mixed-citation>
      </ref>
      <ref id="R23">
        <label>23</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heller</surname><given-names>U</given-names></name><name><surname>Becker</surname><given-names>EW</given-names></name><name><surname>Zenner</surname><given-names>HP</given-names></name><etal/></person-group>
<article-title>Incidence and clinical relevance of antibodies to phospholipids, serotonin and ganglioside in patients with sudden deafness and progressive inner ear hearing loss</article-title>. <source><italic>HNO</italic></source>
<year>1998</year>; <volume>46</volume>:<fpage>583</fpage>&#x2013;<lpage>586</lpage>.<pub-id pub-id-type="pmid">9677490</pub-id></mixed-citation>
      </ref>
      <ref id="R24">
        <label>24</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hisashi</surname><given-names>K</given-names></name><name><surname>Komune</surname><given-names>S</given-names></name><name><surname>Taira</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Anticardiolipin antibody-induced sudden profound sensorineural hearing loss</article-title>. <source><italic>Am J Otol</italic></source>
<year>1993</year>; <volume>14</volume>:<fpage>275</fpage>&#x2013;<lpage>277</lpage>.</mixed-citation>
      </ref>
      <ref id="R25">
        <label>25</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mouadeb</surname><given-names>DA</given-names></name><name><surname>Ruckenstein</surname><given-names>MJ</given-names></name></person-group>
<article-title>Antiphospholipid inner ear syndrome</article-title>. <source><italic>Laryngoscope</italic></source>
<year>2005</year>; <volume>115</volume>:<fpage>879</fpage>&#x2013;<lpage>883</lpage>.<pub-id pub-id-type="pmid">15867658</pub-id></mixed-citation>
      </ref>
      <ref id="R26">
        <label>26</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yue</surname><given-names>WL</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Qi</surname><given-names>PY</given-names></name><etal/></person-group>
<article-title>Role of low-molecular-weight heparins in the treatment of sudden hearing loss</article-title>. <source><italic>Am J Otolaryngol</italic></source>
<year>2003</year>; <volume>24</volume>:<fpage>328</fpage>&#x2013;<lpage>333</lpage>.<pub-id pub-id-type="pmid">13130446</pub-id></mixed-citation>
      </ref>
      <ref id="R27">
        <label>27</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>C</given-names></name><name><surname>Lin</surname><given-names>SW</given-names></name><name><surname>Weng</surname><given-names>SF</given-names></name><etal/></person-group>
<article-title>Risk of sudden sensorineural hearing loss in patients with systemic lupus erythematosus: a population-based cohort study</article-title>. <source><italic>Audiol Neurootol</italic></source>
<year>2013</year>; <volume>18</volume>:<fpage>95</fpage>&#x2013;<lpage>100</lpage>.<pub-id pub-id-type="pmid">23257626</pub-id></mixed-citation>
      </ref>
      <ref id="R28">
        <label>28</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamblin</surname><given-names>TJ</given-names></name><name><surname>Mufti</surname><given-names>GJ</given-names></name><name><surname>Bracewell</surname><given-names>A</given-names></name></person-group>
<article-title>Severe deafness in systemic lupus erythematosus: its immediate relief by plasma exchange</article-title>. <source><italic>Br Med J (Clin Res Ed)</italic></source>
<year>1982</year>; <volume>284</volume>:<fpage>1374</fpage>.</mixed-citation>
      </ref>
      <ref id="R29">
        <label>29</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caldarelli</surname><given-names>DD</given-names></name><name><surname>Rejowski</surname><given-names>JE</given-names></name><name><surname>Corey</surname><given-names>JP</given-names></name></person-group>
<article-title>Sensorineural hearing loss in lupus erythematosus</article-title>. <source><italic>Am J Otol</italic></source>
<year>1986</year>; <volume>7</volume>:<fpage>210</fpage>&#x2013;<lpage>213</lpage>.<pub-id pub-id-type="pmid">3717314</pub-id></mixed-citation>
      </ref>
      <ref id="R30">
        <label>30</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>S</given-names></name><name><surname>Fujishiro</surname><given-names>N</given-names></name><name><surname>Sugiyama</surname><given-names>K</given-names></name></person-group>
<article-title>Systemic lupus erythematosus with sensorineural hearing loss and improvement after plasmapheresis using the double filtration method</article-title>. <source><italic>Intern Med</italic></source>
<year>1992</year>; <volume>31</volume>:<fpage>778</fpage>&#x2013;<lpage>781</lpage>.<pub-id pub-id-type="pmid">1392181</pub-id></mixed-citation>
      </ref>
      <ref id="R31">
        <label>31</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vyse</surname><given-names>T</given-names></name><name><surname>Luxon</surname><given-names>LM</given-names></name><name><surname>Walport</surname><given-names>MJ</given-names></name></person-group>
<article-title>Audiovestibular manifestations of the antiphospholipid syndrome</article-title>. <source><italic>J Laryngol Otol</italic></source>
<year>1994</year>; <volume>108</volume>:<fpage>57</fpage>&#x2013;<lpage>59</lpage>.<pub-id pub-id-type="pmid">8133171</pub-id></mixed-citation>
      </ref>
      <ref id="R32">
        <label>32</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kataoka</surname><given-names>H</given-names></name><name><surname>Takeda</surname><given-names>T</given-names></name><name><surname>Nakatani</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Sensorineural hearing loss of suspected autoimmune etiology: a report of three cases</article-title>. <source><italic>Auris Nasus Larynx</italic></source>
<year>1995</year>; <volume>22</volume>:<fpage>53</fpage>&#x2013;<lpage>58</lpage>.<pub-id pub-id-type="pmid">7677637</pub-id></mixed-citation>
      </ref>
      <ref id="R33">
        <label>33</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paira</surname><given-names>SO</given-names></name></person-group>
<article-title>Sudden sensorineural hearing loss in patients with systemic lupus erythematosus or lupus-like syndrome and antiphospholipid antibodies</article-title>. <source><italic>J Rheumatol</italic></source>
<year>1998</year>; <volume>25</volume>:<fpage>2476</fpage>&#x2013;<lpage>2477</lpage>.<pub-id pub-id-type="pmid">9858454</pub-id></mixed-citation>
      </ref>
      <ref id="R34">
        <label>34</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sone</surname><given-names>M</given-names></name><name><surname>Schachern</surname><given-names>PA</given-names></name><name><surname>Paparella</surname><given-names>MM</given-names></name><etal/></person-group>
<article-title>Study of systemic lupus erythematosus in temporal bones</article-title>. <source><italic>Ann Otol Rhinol Laryngol</italic></source>
<year>1999</year>; <volume>108</volume>:<fpage>338</fpage>&#x2013;<lpage>344</lpage>.<pub-id pub-id-type="pmid">10214779</pub-id></mixed-citation>
      </ref>
      <ref id="R35">
        <label>35</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peeva</surname><given-names>E</given-names></name><name><surname>Barland</surname><given-names>P</given-names></name></person-group>
<article-title>Sensorineural hearing loss in conjunction with aortic insufficiency in systemic lupus erythematosus</article-title>. <source><italic>Scand J Rheumatol</italic></source>
<year>2001</year>; <volume>30</volume>:<fpage>45</fpage>&#x2013;<lpage>47</lpage>.<pub-id pub-id-type="pmid">11252692</pub-id></mixed-citation>
      </ref>
      <ref id="R36">
        <label>36</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mora</surname><given-names>R</given-names></name><name><surname>Mora</surname><given-names>F</given-names></name><name><surname>Passali</surname><given-names>FM</given-names></name><etal/></person-group>
<article-title>Restoration of immune-mediated sensorineural hearing loss with sodium enoxaparin: a case report</article-title>. <source><italic>Acta Otolaryngol Suppl</italic></source>
<year>2004</year>; <volume>552</volume>:<fpage>25</fpage>&#x2013;<lpage>28</lpage>.<pub-id pub-id-type="pmid">15219043</pub-id></mixed-citation>
      </ref>
      <ref id="R37">
        <label>37</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukushima</surname><given-names>N</given-names></name><name><surname>Fukushima</surname><given-names>H</given-names></name><name><surname>Cureoglu</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Hearing loss associated with systemic lupus erythematosus: temporal bone histopathology</article-title>. <source><italic>Otol Neurotol</italic></source>
<year>2006</year>; <volume>27</volume>:<fpage>127</fpage>&#x2013;<lpage>128</lpage>.<pub-id pub-id-type="pmid">16371860</pub-id></mixed-citation>
      </ref>
      <ref id="R38">
        <label>38</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugiura</surname><given-names>M</given-names></name><name><surname>Naganawa</surname><given-names>S</given-names></name><name><surname>Teranishi</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Inner ear hemorrhage in systemic lupus erythematosus</article-title>. <source><italic>Laryngoscope</italic></source>
<year>2006</year>; <volume>116</volume>:<fpage>826</fpage>&#x2013;<lpage>828</lpage>.<pub-id pub-id-type="pmid">16652096</pub-id></mixed-citation>
      </ref>
      <ref id="R39">
        <label>39</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khalidi</surname><given-names>NA</given-names></name><name><surname>Rebello</surname><given-names>R</given-names></name><name><surname>Robertson</surname><given-names>DD</given-names></name></person-group>
<article-title>Sensorineural hearing loss in systemic lupus erythematosus: case report and literature review</article-title>. <source><italic>J Laryngol Otol</italic></source>
<year>2008</year>; <volume>122</volume>:<fpage>1371</fpage>&#x2013;<lpage>1376</lpage>.<pub-id pub-id-type="pmid">18282337</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
